NCT01424176View on ClinicalTrials.gov

Dexpramipexole Renal PK Study

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Amyotrophic Lateral SclerosisRenal Insufficiency

Interventions

DRUG

Dexpramipexole (dose 1)

DRUG

Dexpramipexole (dose 2)

Trial Locations (2)

32809

Research Site, Orlando

55430

Research Site, Brooklyn Center

Sponsors

Lead Sponsor

Knopp Biosciences

All Listed Sponsors

lead

Knopp Biosciences

INDUSTRY